1. Skip to Menu
  2. Skip to Content
  3. Skip to Footer>

Our Blog

Brand Surgical Institute in Glendale Provides Safe and Aesthetic Nipple Reduction Surgery

PDFPrintE-mail

 With nipple reduction surgery, patients are able to achieve more agreeable and complementary nipple and areola size.

Breast enhancement is one of the most common plastic surgery procedures performed worldwide, with hundreds of thousands of women undergoing some form of breast enhancement/correction surgery every year, whether it’s a breast lift, breast reduction, breast reconstruction or breast augmentation procedure.

Read Article

 

The British Lung Foundation has Responded to the Launch of a New Pilot Lung Cancer Screening Programme

PDFPrintE-mail

 Dame Helena Shovelton, Chief Executive of the British Lung Foundation, said: “Lung cancer is the biggest cancer killer with one person losing their life to the disease every 15 minutes so we are delighted to hear the announcement of this screening pilot. Promising results have already come through from a screening programme trialed in the US,

Read Article

 

A New Acute Cardiac Care Test from Randox Offers the Potential to Save Lives and Millions of Pounds to the NHS

PDFPrintE-mail

 Randox Laboratories Ltd. will demonstrate its innovative Cardiac Array and MultiStat at the Healthcare Innovation Expo, taking place at London’s ExCel centre on the 9th and 10th of March, 2011.

This technology measures the biomarker heart fatty-acid binding-protein (H-FABP) in combination with the traditional troponin in chest pain patients in the Emergency Department (ED), which allows earlier diagnosis of heart attacks and risk stratification of chest pain patients within 3-6 hours of chest pain onset. This early diagnosis improves patient treatment and potentially early discharge, and efficiencies, both logistical and financial, within the healthcare system.

Read Article

 

Statins: Benefits Questionable in Low-Risk Patients

PDFPrintE-mail

 There is Not Enough Evidence to Recommend the Widespread use of Statins in People with no Previous History of Heart Disease, According to a New Cochrane Systematic Review.

Researchers say statins should be prescribed with caution in those at low risk of cardiovascular disease (CVD). CVD is the most common cause of death, accounting for nearly a third of all deaths worldwide. Cholesterol-lowering statins are first line treatments for heart patients and the benefits are well established. However,

Read Article

 

Ground-breaking Technology will Revolutionise Blood Pressure Measurement for First Time for over a Century

PDFPrintE-mail

 Pioneering new technology will lead to better treatment decisions and better outcomes for patients

In a major scientific breakthrough, a new blood pressure measurement device is set to revolutionise the way patients’ blood pressure is measured. The new approach, invented by scientists at the University of Leicester and in Singapore, has the potential to enable doctors to treat their patients more effectively because it gives a more accurate reading than the current method used. It does this by measuring the pressure close to the heart ­ the central aortic systolic pressure or CASP.

Read Article

 

Ground-breaking Technology will Revolutionise Blood Pressure Measurement for First Time for over a Century

PDFPrintE-mail

  Pioneering new technology will lead to better treatment decisions and better outcomes for patients

In a major scientific breakthrough, a new blood pressure measurement device is set to revolutionise the way patients’ blood pressure is measured. The new approach, invented by scientists at the University of Leicester and in Singapore, has the potential to enable doctors to treat their patients more effectively because it gives a more accurate reading than the current method used. It does this by measuring the pressure close to the heart ­ the central aortic systolic pressure or CASP.

Read Article

 

Ground-breaking Technology will Revolutionise Blood Pressure Measurement for First Time for over a Century

PDFPrintE-mail

  Pioneering new technology will lead to better treatment decisions and better outcomes for patients

In a major scientific breakthrough, a new blood pressure measurement device is set to revolutionise the way patients’ blood pressure is measured. The new approach, invented by scientists at the University of Leicester and in Singapore, has the potential to enable doctors to treat their patients more effectively because it gives a more accurate reading than the current method used. It does this by measuring the pressure close to the heart ­ the central aortic systolic pressure or CASP.

Read Article

 

Ground-breaking Technology will Revolutionise Blood Pressure Measurement for First Time for over a Century

PDFPrintE-mail

  Pioneering new technology will lead to better treatment decisions and better outcomes for patients

In a major scientific breakthrough, a new blood pressure measurement device is set to revolutionise the way patients’ blood pressure is measured. The new approach, invented by scientists at the University of Leicester and in Singapore, has the potential to enable doctors to treat their patients more effectively because it gives a more accurate reading than the current method used. It does this by measuring the pressure close to the heart ­ the central aortic systolic pressure or CASP.

Read Article

 

Ground-breaking Technology will Revolutionise Blood Pressure Measurement for First Time for over a Century

PDFPrintE-mail

  Pioneering new technology will lead to better treatment decisions and better outcomes for patients

In a major scientific breakthrough, a new blood pressure measurement device is set to revolutionise the way patients’ blood pressure is measured. The new approach, invented by scientists at the University of Leicester and in Singapore, has the potential to enable doctors to treat their patients more effectively because it gives a more accurate reading than the current method used. It does this by measuring the pressure close to the heart ­ the central aortic systolic pressure or CASP.

Read Article

 

Leeds Scientists to Determine Hallmarks of Cervical Cancer

PDFPrintE-mail

 Scientists at the University of Leeds will analyse tissue taken from women with cervical cancer to determine the hallmarks of cells infected with Human Papillomavirus (HPV), responsible for 90 percent of all UK cases. The researchers, funded by Yorkshire Cancer Research, plan to use new techniques for determining human gene sequences to detect and analyse the hallmarks of HPV-infected cervical cancer cells and tissue in order to gain greater understanding of how the virus contributes to the development of the disease.

Read Article

 

Page 9 of 23

Featured Exhibitions

Featured Advertisers

 

 cardiacsci.jpg - 2.83 Kb
sonoscape.jpg 
varian.gif
aneticaid_1.gif